Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339976 · ClinicalTrials.gov registry record
Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis
A clinical trial, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- Completed
- Registry status
NCT00339976: Completed study, sponsored by National Institute of Environmental Health Sciences (NIEHS).
NCT00339976 is a clinical trial that has completed, run by National Institute of Environmental Health Sciences (NIEHS). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339976 has completed, sponsored by National Institute of Environmental Health Sciences (NIEHS).
- COMPLETED
- Registry status
Study Summary
This study is a follow-up to an earlier study that examined the relationship of This study will examine whether exposure to neurotoxins, such as lead, mercury, solvents, and pesticides, can contribute to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The cause of this degenerative disease of the brain and spinal cord is not well understood. Some studies suggest that exposure to environmental neurotoxins may increase its risk. This follow-up study will examine the relationship of neurotoxin exposure to the interval between the diagnosis of ALS and death. It will also examine the possible roles of genetics, lifestyle and dietary factors in the disease. Information on ALS patients previously enrolled in the study will be used to examine this relationship. No new individuals will be enrolled in the study.
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-08-06 |
| Est. Completion | 2008-04-21 |
What the finished NCT00339976 record still lists
NCT00339976 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00339976 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00339976 about?
NCT00339976 is a clinical study titled "Exposure to Neurotoxins as Risk Factors for Amyotrophic Lateral Sclerosis". This study is a follow-up to an earlier study that examined the relationship of This study will examine whether exposure to neurotoxins, such as lead, mercury, solvents, and pesticides, can contribute to amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The cause of this degen...
What is the current status of trial NCT00339976?
This trial is currently completed. The study started on 2002-08-06. Estimated completion is 2008-04-21.
Who is sponsoring clinical trial NCT00339976?
This trial is sponsored by National Institute of Environmental Health Sciences (NIEHS), which has 145 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI